Tigen
Therese Choquette (formerly Vallerskog) is currently the Head of Analytical and Translational Sciences at Tigen, a biotech company focused on the Early Development of Cell Therapies. Prior to their current role, Therese held positions at companies such as Iovance Biotherapeutics, Janssen Inc., Novartis, and Organogenesis, where Therese gained valuable experience in Quality Control, Analytical Science, and R&D. With a PhD in Rheumatology from Karolinska Institutet, Therese has a strong background in immune system research and has demonstrated expertise in assay development and product characterization. Prior to their career in biotech, Therese worked as a Licensed Practical Nurse at St Görans Hospital and Farsta Hospital in Stockholm, Sweden.
This person is not in any offices
Tigen
We are a clinical-stage biotech company in the field of cell therapies to cure cancer. We are a disruptive catalyst, combining a unique culture with a multidisciplinary set of world-class capabilities and a long-term perspective to the benefit of patients and society.